In some cases, combination therapy for Crohn's disease can be more effective than monotherapy (only using one therapy at a time). It involves combining different types of drugs, such as biologic drugs, with immunomodulators. Drugs that work differently provide additional benefits. Early studies su...
TNF inhibitors. They are usually prescribed for moderate or severe Crohn’s disease. These drugs are also known as anti-tumor necrosis factor (anti-TNF). Your doctor may have you tryTNF inhibitorsif immunosuppressants haven’t helped you. You usually get biologic drugs through an IV infusion ...
Lichtenstein GR, Cohen RD, Feagan BG, et al. Use of Crohn's disease medications, including infliximab, are not risk factors for the development of intestinal stricture, steno- sis or obstruction--Data from the 6000-Patient TREAT Reg- istry. Am J Gastroenterol 2004;99(10):S250....
Crohn’s disease is a chronic disease caused by inflammation in the digestive tract. Symptoms can range from mild to severe, but they usually develop gradually. If you see persistent changes in your bowel movements, consider a visit to your provider. Whi
Oral manifestations of Crohn's disease. An analysis of 79 cases. We report four new cases of oral manifestation in Crohn's disease (CD) and evaluate 75 reported cases for morphology and site of oral and intestinal manife... M Plauth,H Jenss,J Meyle - 《Journal of Clinical ...
(6) a diagnosis code during the 180 days prior to the cohort entry date for another immune-mediated inflammatory disorder for which biologics may be used (Crohn disease, ulcerative colitis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, sicca syndrome, rheumatoid arthritis, ...
[16,20]. It was reported that a higher abundance ofIntestinibacteris associated with an increased risk of Crohn’s disease [42] and sleep problems [43]. This suggested that metformin medication could potentially benefit many relevant disorders.Oscillibacterwas reported to be enriched in T2D [44...
维普中文期刊服务平台,是重庆维普资讯有限公司标准化产品之一,本平台以《中文科技期刊数据库》为数据基础,通过对国内出版发行的15000余种科技期刊、7000万篇期刊全文进行内容组织和引文分析,为高校图书馆、情报所、科研机构及企业用户提供一站式文献服务。
A New Drug Class article released on July 4, 2008 in seeks to highlight a new group of drugs intended to treat Crohn's disease. Most current drugs seek to control the autoimmune response via the necrosis factor alpha (TNF-alpha), but many new classes attempt to control other aspects of ...
The influence of medications on the correlation between the Crohn's disease activity index and inflammatory bowel disease questionnaire in patients with Crohn's disease - Gastroenterologydoi:10.1016/S0016-5085(03)80986-1Chinyu SuJames D. Lewis...